Results 81 to 90 of about 28,723 (210)

Apixaban Reduces Hospitalizations in Patients With Venous Thromboembolism: An Analysis of the Apixaban for the Initial Management of Pulmonary Embolism and Deep‐Vein Thrombosis as First‐Line Therapy (AMPLIFY) Trial

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2015
Background In the Apixaban for the Initial Management of Pulmonary Embolism and Deep‐Vein Thrombosis as First‐Line Therapy (AMPLIFY) trial, apixaban was noninferior to enoxaparin/warfarin in preventing recurrent symptomatic venous thromboembolism (VTE ...
Xianchen Liu, Margot Johnson, Jack Mardekian, Hemant Phatak, John Thompson, Alexander T. Cohen   +5 more
doaj   +1 more source

Bilateral Upper Extremity Superficial Venous Thrombosis and Altered Mental Status as Initial Manifestations of Aggressive B‐Cell Lymphoma: A Case Report

Clinical Case Reports, Volume 14, Issue 8, August 2026.
Schematic representation of the disease progression, diagnostic workup, treatment course, and final clinical outcome. ABSTRACT A 72‐year‐old woman with fever, confusion, and upper extremity superficial venous thrombosis was admitted. Despite screening for infectious, neurologic, and autoimmune causes, no diagnosis was established.
Milad Rezvani, Mahdi Naeiji, Hasan Maghsoudifar, Sepehr Zamani, Maryam Yarmohammadi, Maryam Valikhani   +5 more
wiley   +1 more source

Bullous hemorrhagic dermatosis induced by enoxaparin

, 2015
© 2015 Informa Healthcare USA, Inc.The bullous hemorrhagic dermatosis induced by enoxaparin is a rare adverse reaction, which may be under-reported given its favorable evolution.
Soares-de-Almeida, Luís, Lopes, Leonor, Filipe, Paulo, Gouveia, Ana Isabel   +3 more
core   +1 more source

Enoxaparin-sodium [PDF]

Reactions Weekly, 2021
  +5 more sources

Effect of enoxaparin on macroscopic appearance of colon.

, 2015
(A) Representative images of colons from mice treated with and without enoxaparin. (B) The colons were measured for their length. (C) The appearance of colon luminal content was evaluated before the measurement of colon weight.
Sarron Randall-Demllo (776243), Rahul P. Patel (698431), Niall Stewart (698428), Sukhwinder Singh Sohal (317561), Nuri Gueven (134653), Rajaraman D. Eri (755888), Qi Ying Lean (755887), Gregory M. Peterson (564167)   +7 more
core   +1 more source

The Efficacy of Low-Dose Enoxaparin in Psoriasis

, 2022
Psoriasis is a frequently encountered inflammatory skin disease with unclear etiology and no curative therapy. Enoxaparin is a low-molecular weight heparin analogue.
Atakan, Nilgün, Demircioğlu, Deniz
core   +1 more source

Orally Administered Enoxaparin Ameliorates Acute Colitis by Reducing Macrophage-Associated Inflammatory Responses.

PLoS ONE, 2015
Inflammatory bowel diseases, such as ulcerative colitis, cause significant morbidity and decreased quality of life. The currently available treatments are not effective in all patients, can be expensive and have potential to cause severe side effects ...
Qi Ying Lean, Rajaraman D Eri, Sarron Randall-Demllo, Sukhwinder Singh Sohal, Niall Stewart, Gregory M Peterson, Nuri Gueven, Rahul P Patel   +7 more
doaj   +1 more source

Increased Enoxaparin Dosing Is Required for Obese Children

, 2011
Weight-based dosing for enoxaparin is recommended in the 2008 American College of Chest Physicians (ACCP) guidelines for venous thromboembolism (VTE) prophylaxis. Enoxaparin 0.5 mg/kg per dose administered subcutaneously every 12 hours is recommended for
Marny Dunlap, Teresa V. Lewis, Peter N. Johnson, Ashley M. Nebbia   +3 more
core   +1 more source

Safety of concomitant therapy with eptifibatide and enoxaparin in patients undergoing percutaneous coronary intervention: Results of the coronary revascularization using integrilin and single bolus enoxaparin study [PDF]

, 2003
ObjectivesThis study was designed to assess whether use of enoxaparin during percutaneous coronary intervention (PCI) increased bleeding compared with unfractionated heparin, in addition to background therapy with eptifibatide.BackgroundData supporting ...
Breall, Jeffrey A, Lincoff, A.Michael, Bhatt, Deepak L, Sklar, Mitchel A, Lee, Benjamin I, Casterella, Peter J, Ryan, Thomas J, Rogers, Matthew, Eaton, Gregory M, Moses, Jeffrey W, Pulsipher, Mark, Corrigan, Victor E, Cohen, Marc   +12 more
core   +1 more source

Diversity in Translation: Equal Is Greater Than

Clinical and Translational Science, Volume 19, Issue 9, September 2026.
Elvin T. Price, John A. Wagner
wiley   +1 more source